Search research articles
Contact Us
Filters
Showing results (301-310 of 520) with videos related to
Page
of 52
Sort By:
Diabetes Technology & Therapeutics
|
September 2, 2025
Biases in Glucose Metrics Are Directly Related to Low Coverage of Continuous Glucose Monitoring: Insights from Diverse Populations
Simon Lebech Cichosz, Niels Væver Hartvig, Thomas Kronborg, et al.
World Journal of Surgery
|
March 5, 2003
Cardiovascular events before and after surgery for primary hyperparathyroidism
Peter Vestergaard, Charlotte L Mollerup, Vibe Gedsø Frøkjaer, et al.
Thyroid : Official Journal of the American Thyroid Association
|
September 23, 2014
Aggressive medullary thyroid carcinoma in a ten-year-old patient with multiple endocrine neoplasia 2B due to the A883F mutation
Jes Sloth Mathiesen, Kirstine Stochholm, Per Loegstrup Poulsen, et al.
Journal of Diabetes Science and Technology
|
December 29, 2023
A Three-Step Data-Driven Methodology to Assess Adherence to Basal Insulin Therapy in Patients With Insulin-Treated Type 2 Diabetes
Jannie Toft Damsgaard Nørlev, Thomas Kronborg, Morten Hasselstrøm Jensen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
April 8, 2004
Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women
Lars Rejnmark, Niels Henrik Buus, Peter Vestergaard, et al.
European Journal of Endocrinology
|
September 13, 2008
Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism
Signe Engkjaer Christensen, Peter H Nissen, Peter Vestergaard, et al.
The Journal of Pediatrics
|
May 6, 2004
Reduced bone mineral density and increased bone turnover in Prader-Willi syndrome compared with controls matched for sex and body mass index--a cross-sectional study
Peter Vestergaard, Kurt Kristensen, Jens M Bruun, et al.
Frontiers in Endocrinology
|
October 27, 2022
The risk of major osteoporotic fractures with GLP-1 receptor agonists when compared to DPP-4 inhibitors: A Danish nationwide cohort study
Zheer Kejlberg Al-Mashhadi, Rikke Viggers, Rasmus Fuglsang-Nielsen, et al.
Clinical Endocrinology
|
March 3, 2009
Skeletal consequences of familial hypocalciuric hypercalcaemia vs. primary hyperparathyroidism
Signe Engkjaer Christensen, Peter H Nissen, Peter Vestergaard, et al.
Current Drug Safety
|
November 13, 2013
Use of thiazolidinediones and risk of bladder cancer: disease or drugs?
Marloes T Bazelier, Frank de Vries, Peter Vestergaard, et al.
Page
of 52
Search research articles
Search
Showing results (301-310 of 520) with videos related to
Sort By:
Page
of 52
Diabetes Technology & Therapeutics
|
September 2, 2025
Biases in Glucose Metrics Are Directly Related to Low Coverage of Continuous Glucose Monitoring: Insights from Diverse Populations
Simon Lebech Cichosz, Niels Væver Hartvig, Thomas Kronborg, et al.
World Journal of Surgery
|
March 5, 2003
Cardiovascular events before and after surgery for primary hyperparathyroidism
Peter Vestergaard, Charlotte L Mollerup, Vibe Gedsø Frøkjaer, et al.
Thyroid : Official Journal of the American Thyroid Association
|
September 23, 2014
Aggressive medullary thyroid carcinoma in a ten-year-old patient with multiple endocrine neoplasia 2B due to the A883F mutation
Jes Sloth Mathiesen, Kirstine Stochholm, Per Loegstrup Poulsen, et al.
Journal of Diabetes Science and Technology
|
December 29, 2023
A Three-Step Data-Driven Methodology to Assess Adherence to Basal Insulin Therapy in Patients With Insulin-Treated Type 2 Diabetes
Jannie Toft Damsgaard Nørlev, Thomas Kronborg, Morten Hasselstrøm Jensen, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
April 8, 2004
Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women
Lars Rejnmark, Niels Henrik Buus, Peter Vestergaard, et al.
European Journal of Endocrinology
|
September 13, 2008
Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism
Signe Engkjaer Christensen, Peter H Nissen, Peter Vestergaard, et al.
The Journal of Pediatrics
|
May 6, 2004
Reduced bone mineral density and increased bone turnover in Prader-Willi syndrome compared with controls matched for sex and body mass index--a cross-sectional study
Peter Vestergaard, Kurt Kristensen, Jens M Bruun, et al.
Frontiers in Endocrinology
|
October 27, 2022
The risk of major osteoporotic fractures with GLP-1 receptor agonists when compared to DPP-4 inhibitors: A Danish nationwide cohort study
Zheer Kejlberg Al-Mashhadi, Rikke Viggers, Rasmus Fuglsang-Nielsen, et al.
Clinical Endocrinology
|
March 3, 2009
Skeletal consequences of familial hypocalciuric hypercalcaemia vs. primary hyperparathyroidism
Signe Engkjaer Christensen, Peter H Nissen, Peter Vestergaard, et al.
Current Drug Safety
|
November 13, 2013
Use of thiazolidinediones and risk of bladder cancer: disease or drugs?
Marloes T Bazelier, Frank de Vries, Peter Vestergaard, et al.
Page
of 52